logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
A

Anti-Cancer Drugs

IF2.2
论文数50
被引数4204
期刊论文 50
发表时间
delete
Initial stage analysis of tislelizumab in combination with chemotherapy for patients with advanced HIV-positive non-small-cell lung cancer: a comparative clinical trial替雷利珠单抗联合化疗治疗HIV阳性晚期非小细胞肺癌的初始阶段分析：一项比较临床试验
deleteAnti-Cancer Drugs
IF2.2
delete2026-04-01
delete1
PREAI
deleteQuan, Yaping; Li, Hao; Liang, Zhengjie; Shen, Jie; Hu, Yong
delete分享
delete收藏
EP4 influences bortezomib resistance in multiple myeloma by modulating endoplasmic reticulum stress via the phosphatidylinositol 3-kinase/protein kinase B pathwayEP4通过磷脂酰肌醇3-激酶/蛋白激酶B通路调控内质网应激影响硼替佐米耐药性在多发性骨髓瘤中的作用
deleteAnti-Cancer Drugs
IF2.2
delete2026-04-01
delete0
PREAI
deleteShi, Tengfei; Chen, Yao; Liu, Zhiqiang; Liu, Aichun
delete分享
delete收藏
Locoregional and symptomatic response to neoadjuvant dual HER2 blockade with chemotherapy in HER2-positive breast cancer: a pilot study局部区域和症状性反应对HER2阳性乳腺癌新辅助治疗中化疗联合双HER2阻断的疗效：一项初步研究
deleteAnti-Cancer Drugs
IF2.2
delete2026-04-01
delete0
PREAI
deleteChowdhary, Gurjeet Singh; Nayyar, Ankush; Vasudevan, Sridharan; Kaur, Kamalpreet
delete分享
delete收藏
Comparative efficacy and safety of S-1 plus oxaliplatin with sintilimab vs. paclitaxel-S-1-oxaliplatin and docetaxel-oxaliplatin-5-fluorouracil as first-line therapy for advanced gastric cancerS-1联合奥沙利铂与信迪利单抗对比紫杉醇-S-1-奥沙利铂及多西他赛-奥沙利铂-5-氟尿嘧啶作为晚期胃癌一线治疗的疗效与安全性比较
deleteAnti-Cancer Drugs
IF2.2
delete2026-04-01
delete0
PREAI
deleteWang, Yicong; Ma, Bingyang; Zhang, Chenguang; Wang, Yuwen; Pan, Ting; Zhao, Chunlong; Cai, Baojia; Yu, Pengjie; Guo, Bin; Ma, Jinfu
delete分享
delete收藏
Multimodal treatment with thiotepa, bevacizumab, teniposide, and tunlametinib in a patient with neurofibromatosis type 1-associated oligodendroglioma: a rare case report神经纤维瘤病1型相关少突胶质细胞瘤患者的多模式治疗（硫替派、贝伐珠单抗、替尼泊苷和Tunlametinib）：一例罕见病例报告
deleteAnti-Cancer Drugs
IF2.2
delete2026-04-01
delete0
PREAI
deleteZhou, Shizhen; Chen, Yanfei; Gao, Guoliang; Pan, Xueqiang; Sun, Peng; Tao, Rongjie
delete分享
delete收藏
Histone lactylation promoted colorectal cancer progression by enhancing tumor necrosis factor transcription and served as a diagnostic biomarker组蛋白乳酰化通过增强肿瘤坏死因子转录促进结直肠癌进展，并作为诊断生物标志物
deleteAnti-Cancer Drugs
IF2.2
delete2026-03-01
delete1
PREAI
deleteLi, Shiyang; Shi, Xiufang; Zhou, Xiaoyue
delete分享
delete收藏
Clinical importance of the interactions between the TGF-β1/SMAD and NF-κB pathways in colorectal cancer and the study of the synergistic regulatory mechanism of the STAT3-mediated pathway转化生长因子-β1/SMAD与核因子-κB通路在结直肠癌中的相互作用及其临床意义，以及STAT3介导通路协同调控机制的研究
deleteAnti-Cancer Drugs
IF2.2
delete2026-03-01
delete0
PREAI
deleteChao, Huang; Liu, Haosheng; Shen, Weizeng
delete分享
delete收藏
The evolving landscape of KRAS-targeted therapy: mechanisms of resistance and emerging strategiesKRAS靶向治疗的演变格局：耐药机制与新兴策略
deleteAnti-Cancer Drugs
IF2.2
delete2026-03-01
delete0
PREAI
deletePilco-Janeta, Daniel F.; De la Cruz-Puebla, Myriam
delete分享
delete收藏
Apatinib triggers ferroptosis in gastric cancer via HDAC1/HIF1α/CA9 signaling axis阿帕替尼通过HDAC1/HIF1α/CA9信号轴诱导胃癌发生铁死亡
deleteAnti-Cancer Drugs
IF2.2
delete2026-03-01
delete0
PREAI
deleteMeng, Lijuan; Cao, Lei; Lu, Yueyao; Yang, Lixin; Zhu, Weiyou
delete分享
delete收藏
Activation of the caspase-1/gasdermin D pathway via α-linolenic acid-mediated GPR120 signaling induces pyroptosis and suppresses ovarian cancer tumor growth通过α-亚麻酸介导的GPR120信号通路激活caspase-1/gasdermin D通路诱导焦亡并抑制卵巢癌肿瘤生长
deleteAnti-Cancer Drugs
IF2.2
delete2026-03-01
delete1
PREAI
deleteSun, Shijie; Qian, Li
delete分享
delete收藏
Identification of uridine phosphatase 1 as a potential therapeutic target in gastric cancer by integrated bioinformatics analysis and experimental validation通过整合生物信息学分析和实验验证，鉴定尿苷磷酸酶1为胃癌的潜在治疗靶点
deleteAnti-Cancer Drugs
IF2.2
delete2026-03-01
delete0
PREAI
deleteWang, Yongfeng; Feng, Yichen; Zhu, Chengzhang; Guan, Ling; Wang, Shengfeng; Zou, Anqi; Yu, Miao; Yuan, Yuan; Cai, Hui
delete分享
delete收藏
Collagen I is the effective therapeutic target for treating desmoid tumorsI型胶原蛋白是治疗硬纤维瘤的有效治疗靶点
deleteAnti-Cancer Drugs
IF2.2
delete2026-03-01
delete0
PREAI
deleteLee, Yehyeong; Kim, Yonghyo; Lee, Chankyoung; Kim, Tae Il; Cho, Yong-Hee
delete分享
delete收藏
Successful treatment with erlotinib plus ramucirumab in a patient with non-small-cell lung cancer harboring EGFR exon 20 insertion mutation中村K.; 山冈K.; 宇部田Y.; 和田村Y. 使用厄洛替尼联合雷莫芦单抗成功治疗携带EGFR外显子20插入突变的患者非小细胞肺癌。抗癌药物2026, 37, 120–122. [谷歌学术] [交叉引用]
deleteAnti-Cancer Drugs
IF2.2
delete2026-02-01
delete1
PREAI
deleteNakashima, Koki; Yamaoka, Koji; Umeda, Yukihiro; Waseda, Yuko
delete分享
delete收藏
Anti-CD19 antibody tafasitamab therapy for relapsed or refractory diffuse large B-cell lymphoma: a case series抗CD19抗体塔法西他单抗治疗复发或难治性弥漫大B细胞淋巴瘤：一例病例系列
deleteAnti-Cancer Drugs
IF2.2
delete2026-02-01
delete1
PREAI
deleteYou, Jianhua; Chen, Wenting; Yan, Zixun; Tian, Dengmei; Yi, Hongmei; Feng, Yuan; Zhang, Mengping; Xing, Tingting; Wang, Zhi; Zhao, Weili; Xu, Pengpeng
delete分享
delete收藏
A genome-wide screen identified ARHGAP35 as a regulator of regorafenib resistance in liver cancer全基因组筛选鉴定ARHGAP35为肝癌中瑞戈非尼耐药性的调节因子
deleteAnti-Cancer Drugs
IF2.2
delete2026-02-01
delete1
PREAI
deleteChen, Kun; Zhang, Miaomiao; Liu, Yuexin; Dong, Zhengnan; Liang, Yaoji; Zeng, Jinzhang; Liu, Jie
delete分享
delete收藏
A novel anticancer natural product SP09 selectively targets KRAS-mutant NSCLC through LKB1/AMPK/mTOR modulation: implications for novel therapeutic development一种新型抗癌天然产物SP09通过LKB1/AMPK/mTOR调控选择性靶向KRAS突变型NSCLC：对新型治疗开发的启示
deleteAnti-Cancer Drugs
IF2.2
delete2026-02-01
delete0
PREAI
deleteYue, Peng; Hon, Chitin; Zhao, Xiaoping; Ali, Fayaz; Sun, Jiayi; Kou, Jiyou
delete分享
delete收藏
Adiponectin Receptor 1-vascular endothelial growth factor axis mediates resistance to epidermal growth factor receptor-targeted therapy in nasopharyngeal carcinoma脂联素受体1-血管内皮生长因子轴介导鼻咽癌对表皮生长因子受体靶向治疗的耐药性
deleteAnti-Cancer Drugs
IF2.2
delete2026-02-01
delete0
PREAI
deleteCheng, Zilu; Peng, Xiaohong; Wu, Shuting; Li, Wanxia; Liu, Xiong; Zhang, Guohua
delete分享
delete收藏
Serum heat shock protein family A member 9 protein as a biomarker for bortezomib resistance and poor prognosis in patients with multiple myeloma血清热休克蛋白家族A成员9蛋白作为多发性骨髓瘤患者硼替佐米耐药和不良预后的生物标志物
deleteAnti-Cancer Drugs
IF2.2
delete2026-02-01
delete0
PREAI
deleteChen, Lin; Gao, Shuang; Lin, Li; Liu, Su; Ma, Jing; Zhang, Zhiying; Li, Qian
delete分享
delete收藏
Distribution of side effects of anti-EGFR treatments in patients with metastatic colorectal cancer and evaluation of their relationship with survival抗表皮生长因子受体治疗在转移性结直肠癌患者中的副作用分布及其与生存期的关系评估
deleteAnti-Cancer Drugs
IF2.2
delete2026-02-01
delete1
PREAI
deleteErciyestepe, Mert; Aydin, Okan; Sonusen, Sermin Dinc; Ozturk, Ahmet Emin; Celik, Emir; Atci, Muhammed Mustafa; Erturk, Kayhan
delete分享
delete收藏
Low relative dose intensity adjuvant chemotherapy in elderly patients with breast cancer: predictors and impact on survival老年乳腺癌患者辅助化疗的低相对剂量强度：预测因素及其对生存的影响
deleteAnti-Cancer Drugs
IF2.2
delete2026-02-01
delete0
PREAI
deleteRamos-Esquivel, Allan; Romero-Orocu, David; Mora-Hidalgo, Raquel
delete分享
delete收藏